Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,057 | 188 | 98.5% |
| Education | $45.45 | 2 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $899.53 | 60 | $0 (2024) |
| PFIZER INC. | $293.47 | 15 | $0 (2024) |
| ABBVIE INC. | $269.17 | 13 | $0 (2024) |
| Lilly USA, LLC | $209.83 | 12 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $129.47 | 10 | $0 (2021) |
| GlaxoSmithKline, LLC. | $120.99 | 8 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $100.30 | 6 | $0 (2021) |
| Sumitomo Pharma America, Inc. | $86.80 | 4 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $80.21 | 5 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $74.08 | 5 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $564.34 | 29 | Novo Nordisk Inc ($209.64) |
| 2023 | $241.03 | 12 | Novo Nordisk Inc ($70.81) |
| 2022 | $405.21 | 23 | Novo Nordisk Inc ($183.78) |
| 2021 | $438.17 | 29 | Novo Nordisk Inc ($172.82) |
| 2020 | $292.48 | 18 | Novo Nordisk Inc ($76.00) |
| 2019 | $289.86 | 20 | Novo Nordisk Inc ($53.69) |
| 2018 | $404.57 | 25 | PFIZER INC. ($122.78) |
| 2017 | $466.70 | 34 | Novo Nordisk Inc ($117.85) |
All Payment Transactions
190 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: UROLOGY | ||||||
| 11/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: PAIN | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Diabetes | ||||||
| 11/02/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $28.71 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: UROLOGY | ||||||
| 10/17/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: UROLOGY | ||||||
| 08/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Diabetes | ||||||
| 08/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: RESPIRATORY | ||||||
| 07/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Diabetes | ||||||
| 07/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Biological | ||||||
| 07/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Diabetes | ||||||
| 06/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: PAIN | ||||||
| 05/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Diabetes | ||||||
| 05/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Diabetes | ||||||
| 04/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: RESPIRATORY | ||||||
| 04/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: Diabetes | ||||||
| 03/29/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Endocrinology | ||||||
| 03/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Diabetes | ||||||
| 02/27/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Diabetes | ||||||
| 02/23/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 572 | 662 | $75,605 | $52,278 |
| 2022 | 8 | 626 | 730 | $76,061 | $53,029 |
| 2021 | 9 | 747 | 964 | $102,371 | $72,005 |
| 2020 | 11 | 752 | 939 | $99,123 | $58,726 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 217 | 217 | $29,295 | $24,525 | 83.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 95 | 135 | $18,900 | $9,482 | 50.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 102 | 151 | $14,647 | $7,312 | 49.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 50 | 50 | $4,023 | $3,563 | 88.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $3,850 | $3,112 | 80.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 16 | 16 | $2,640 | $2,325 | 88.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 56 | 56 | $1,680 | $1,590 | 94.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $330.00 | $317.90 | 96.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 14 | 15 | $240.00 | $51.15 | 21.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 204 | 204 | $27,540 | $24,775 | 90.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 150 | 220 | $21,340 | $10,685 | 50.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 129 | $18,060 | $9,330 | 51.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 56 | 56 | $4,193 | $3,860 | 92.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 16 | 16 | $2,640 | $2,554 | 96.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 59 | 59 | $1,466 | $1,437 | 98.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 12 | 12 | $278.00 | $273.12 | 98.2% |
| 81002 | Urinalysis, manual test | Office | 2022 | 28 | 34 | $544.00 | $114.65 | 21.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 212 | 212 | $28,620 | $26,708 | 93.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 214 | 362 | $35,114 | $20,235 | 57.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 135 | 191 | $26,740 | $14,939 | 55.9% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 55 | 55 | $3,464 | $3,388 | 97.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 20 | 20 | $3,300 | $3,240 | 98.2% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 12 | 12 | $2,820 | $2,112 | 74.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 60 | 60 | $810.00 | $806.30 | 99.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 11 | 11 | $847.00 | $436.92 | 51.6% |
About Dr. Kelli Dumm, MD
Dr. Kelli Dumm, MD is a Internal Medicine healthcare provider based in Charleston, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760461164.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kelli Dumm, MD has received a total of $3,102 in payments from pharmaceutical and medical device companies, with $564.34 received in 2024. These payments were reported across 190 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($3,057).
As a Medicare-enrolled provider, Dumm has provided services to 2,697 Medicare beneficiaries, totaling 3,295 services with total Medicare billing of $236,038. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Charleston, WV
- Active Since 01/13/2006
- Last Updated 08/07/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1760461164
Products in Payments
- Ozempic (Drug) $548.60
- Rybelsus (Drug) $186.71
- ELIQUIS (Drug) $161.54
- UBRELVY (Drug) $135.08
- QULIPTA (Drug) $117.36
- NURTEC ODT (Drug) $114.16
- Victoza (Drug) $90.27
- FARXIGA (Drug) $89.92
- TRINTELLIX (Drug) $89.43
- GEMTESA (Drug) $86.80
- TRELEGY ELLIPTA (Drug) $81.29
- XARELTO (Drug) $80.21
- MOUNJARO (Drug) $65.36
- CHANTIX (Drug) $61.52
- JANUVIA (Drug) $60.83
- TRULICITY (Drug) $58.46
- Trulance (Drug) $56.88
- TROKENDI XR (Drug) $56.68
- Trintellix (Drug) $55.15
- EMGALITY (Drug) $52.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Charleston
William Chapman, Do, DO
Internal Medicine — Payments: $1.3M
Dr. Ryan Tedford, M.d, M.D
Internal Medicine — Payments: $432,170
Harold Szerlip, Md, MD
Internal Medicine — Payments: $284,278
Dr. Nathan Shores, M.d, M.D
Internal Medicine — Payments: $262,570
Hamza Hashmi, M.d, M.D
Internal Medicine — Payments: $234,146
Dr. Anne Kroman, D.o., Phd, D.O., PHD
Internal Medicine — Payments: $202,518